See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $153B | 0.4x | 10.1x | |
| $38.7B | 0.3x | 10.2x | |
| $27.1B | 8.4x | 33.8x | |
| $9.2B | 2.2x | 35.6x | |
| $8.1B | 1.0x | 19.5x | |
| $7.3B | 0.2x | 3.4x | |
| $6.8B | 0.9x | 9.5x | |
| $6.6B | 0.6x | 11.4x | |
| $6.0B | 0.8x | 9.9x | |
| $5.2B | 2.0x | 15.2x | |
| $4.9B | 0.7x | 11.5x | |
| $4.3B | 1.7x | 10.0x | |
| $4.2B | 1.2x | 10.7x | |
| $3.9B | 0.4x | 9.4x | |
| $3.8B | 0.6x | 9.0x | |
| $3.7B | 0.2x | 5.7x | |
| $3.7B | 0.7x | 8.3x | |
| $3.6B | 0.6x | 8.3x | |
| $2.9B | 1.0x | 57.8x | |
| $2.9B | 0.8x | 6.5x | |
| $2.8B | 0.8x | 11.0x | |
| $2.5B | 0.8x | 7.5x | |
| $2.4B | 1.3x | 9.7x | |
| $2.2B | 0.3x | 4.4x | |
| $1.8B | 2.2x | 6.7x | |
| $1.8B | 0.8x | 10.0x | |
| $1.4B | 0.4x | 6.1x | |
| $1.2B | 1.6x | 20.5x | |
| $1.2B | 1.1x | 9.4x | |
| $1.2B | 0.4x | n/a | |
| $1.1B | 0.4x | 9.1x | |
| $1.1B | n/a | n/a | |
| $995M | n/a | n/a | |
| $974M | 0.4x | 6.7x | |
| $973M | n/a | n/a | |
| $926M | 0.7x | n/a | |
| $850M | 1.4x | 15.9x | |
| $722M | n/a | n/a | |
| $666M | n/a | n/a | |
| $627M | n/a | n/a | |
| $534M | 0.4x | -11.0x | |
| $411M | 0.2x | 17.8x | |
| $279M | 0.1x | n/a | |
| $270M | n/a | n/a | |
| $220M | n/a | n/a | |
| $218M | 0.5x | 9.1x | |
| $135M | 0.1x | 3.6x | |
| $110M | n/a | n/a | |
| $70.1M | 0.5x | 13.5x | |
| $46.2M | n/a | n/a | |
| $29.0M | 0.4x | 47.5x | |
| $26.9M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies